[Therapy with azithromycin in pediatric infections]

Area of Science:

• Pediatric Infectious Diseases
• Pharmacology
• Microbiology

Context:

• Bacterial infections pose a significant health challenge in pediatric populations.
• Effective and well-tolerated antibiotic options are crucial for treating childhood infections.
• Azithromycin is a macrolide antibiotic with broad-spectrum activity.

Purpose:

• To evaluate the efficacy and safety of oral Azithromycin (AZM) in pediatric patients with various bacterial infections.
• To assess patient tolerance of the Azithromycin formulation.

Summary:

• A study involved 12 pediatric patients diagnosed with pharyngitis, tonsillitis, pharyngo-bronchitis, or mycoplasmal pneumonia.
• Azithromycin was administered orally, resulting in an 91.7% effectiveness rate across the treated cases.
• No adverse clinical or laboratory findings were reported, and the drug formulation was reported as easy to administer by most patients.

Impact:

• Azithromycin demonstrates significant therapeutic potential as a useful antibiotic for pediatric bacterial infections.
• The findings support the use of Azithromycin in pediatric clinical practice due to its efficacy and favorable safety profile.
• This study contributes to the evidence base for Azithromycin's role in managing common childhood bacterial infections.